148 related articles for article (PubMed ID: 10391558)
1. K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix.
Ramnani DM; Wistuba II; Behrens C; Gazdar AF; Sobin LH; Albores-Saavedra J
Cancer; 1999 Jul; 86(1):14-21. PubMed ID: 10391558
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
[TBL] [Abstract][Full Text] [Related]
3. Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix.
Jesinghaus M; Konukiewitz B; Foersch S; Stenzinger A; Steiger K; Muckenhuber A; Groß C; Mollenhauer M; Roth W; Detlefsen S; Weichert W; Klöppel G; Pfarr N; Schlitter AM
Mod Pathol; 2018 May; 31(5):829-839. PubMed ID: 29327707
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
5. Goblet cell carcinoid of the appendix: a specific type of carcinoma.
van Eeden S; Offerhaus GJ; Hart AA; Boerrigter L; Nederlof PM; Porter E; van Velthuysen ML
Histopathology; 2007 Dec; 51(6):763-73. PubMed ID: 18042066
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
7. Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids.
Paraskevakou H; Saetta A; Skandalis K; Tseleni S; Athanassiadis A; Davaris PS
Pathol Oncol Res; 1999; 5(3):205-10. PubMed ID: 10491018
[TBL] [Abstract][Full Text] [Related]
8. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
[TBL] [Abstract][Full Text] [Related]
9. EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix.
Dimmler A; Geddert H; Faller G
Pathol Res Pract; 2014 May; 210(5):274-8. PubMed ID: 24560515
[TBL] [Abstract][Full Text] [Related]
10. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors.
Younes N; Fulton N; Tanaka R; Wayne J; Straus FH; Kaplan EL
Cancer; 1997 May; 79(9):1804-8. PubMed ID: 9128999
[TBL] [Abstract][Full Text] [Related]
11. Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas.
Johncilla M; Stachler M; Misdraji J; Lisovsky M; Yozu M; Lindeman N; Lauwers GY; Odze RD; Srivastava A
Mod Pathol; 2018 Jun; 31(6):989-996. PubMed ID: 29422640
[TBL] [Abstract][Full Text] [Related]
12. Combined classical carcinoid and goblet cell carcinoid tumor: a new morphologic variant of carcinoid tumor of the appendix.
Chetty R; Klimstra DS; Henson DE; Albores-Saavedra J
Am J Surg Pathol; 2010 Aug; 34(8):1163-7. PubMed ID: 20631606
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterization of Appendiceal Goblet Cell Carcinoid.
Arai H; Baca Y; Battaglin F; Kawanishi N; Wang J; Soni S; Zhang W; Millstein J; Johnston C; Goldberg RM; Philip PA; Seeber A; Xiu J; Hwang JJ; Shields AF; Marshall JL; Korn WM; Lenz HJ
Mol Cancer Ther; 2020 Dec; 19(12):2634-2640. PubMed ID: 33037134
[TBL] [Abstract][Full Text] [Related]
14. Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms.
Couce ME; Bautista D; Costa J; Carter D
Diagn Mol Pathol; 1999 Jun; 8(2):71-9. PubMed ID: 10475381
[TBL] [Abstract][Full Text] [Related]
15. p53 and ras mutations in Ewing's sarcoma.
Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
[TBL] [Abstract][Full Text] [Related]
16. Ki-ras gene mutations are invariably present in low-grade mucinous tumors of the vermiform appendix.
Zauber P; Berman E; Marotta S; Sabbath-Solitare M; Bishop T
Scand J Gastroenterol; 2011 Jul; 46(7-8):869-74. PubMed ID: 21443421
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
18. Synchronous colon carcinomas: molecular-genetic evidence for multicentricity.
Koness RJ; King TC; Schechter S; McLean SF; Lodowsky C; Wanebo HJ
Ann Surg Oncol; 1996 Mar; 3(2):136-43. PubMed ID: 8646513
[TBL] [Abstract][Full Text] [Related]
19. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
20. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.
Itoi T; Takei K; Shinohara Y; Takeda K; Nakamura K; Horibe T; Sanada A; Ohno H; Matsubayashi H; Saito T; Watanabe H
Pathol Int; 1999 Jan; 49(1):30-7. PubMed ID: 10227722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
